The associations of incretin hormone concentration with gestational diabetes mellitus

Background: Enteropancreatic hormonal system disorder is a possible reason for β-cell dysfunction and carbohydrate metabolism disorder among pregnant women. However, no information is available about the state of enteroinsulin hormones [glucagon, glucose-dependent insulinotropic peptide (GIP), gluca...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatiana V. Saprina, Ekaterina S. Timokhina, Olga K. Goncharevich, Svetlana V. Budeeva, Tatiana S. Prokhorenko, Lyubov A. Tashireva, Nadezhda N. Musina, Irina V. Dronova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2016
Materias:
Acceso en línea:https://doaj.org/article/152a9f78f6864022a6056a32d20297ce
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:152a9f78f6864022a6056a32d20297ce
record_format dspace
spelling oai:doaj.org-article:152a9f78f6864022a6056a32d20297ce2021-11-14T09:00:20ZThe associations of incretin hormone concentration with gestational diabetes mellitus2072-03512072-037810.14341/DM2004134-37https://doaj.org/article/152a9f78f6864022a6056a32d20297ce2016-05-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7026https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background: Enteropancreatic hormonal system disorder is a possible reason for β-cell dysfunction and carbohydrate metabolism disorder among pregnant women. However, no information is available about the state of enteroinsulin hormones [glucagon, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide1 (GLP-1) and GLP-2] during pregnancy. The role of enteroinsulin hormones in the development of carbohydrate metabolism disorder during pregnancy is poorly understood. Aim: To quantify and compare incretin hormone secretion in groups of pregnant women with and without gestational diabetes mellitus (GDM). Materials and methods: The study included 80 patients, 50 of whom had GDM, and the control group consisted of 30 pregnant women without GDM. All patients underwent an oral glucose tolerance test; glycated haemoglobin (HbA1c) estimation; ferritin, transferrin, basal and postprandial glucagon estimation; GLP-1 and GLP-2 estimation. Results: Basal glucagon and GLP-1 levels were significantly higher (p <0. 05) in the group of women with GDM than in the control group. The most significant differences in GLP-1, basal and postprandial glucagon levels were observed during the first trimester of pregnancy. Conclusion: High GLP-1 levels in the group of women with GDM may reflect a state of ‘incretin resistance’, which is similar to hyperinsulinemia in the early stages of type 2 diabetes mellitus.Tatiana V. SaprinaEkaterina S. TimokhinaOlga K. GoncharevichSvetlana V. BudeevaTatiana S. ProkhorenkoLyubov A. TashirevaNadezhda N. MusinaIrina V. DronovaEndocrinology Research Centrearticlegestational diabetes mellitusincretinsglucagonglucagon-like peptide-1glucagon-like peptide-2Nutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 2, Pp 150-157 (2016)
institution DOAJ
collection DOAJ
language EN
RU
topic gestational diabetes mellitus
incretins
glucagon
glucagon-like peptide-1
glucagon-like peptide-2
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle gestational diabetes mellitus
incretins
glucagon
glucagon-like peptide-1
glucagon-like peptide-2
Nutritional diseases. Deficiency diseases
RC620-627
Tatiana V. Saprina
Ekaterina S. Timokhina
Olga K. Goncharevich
Svetlana V. Budeeva
Tatiana S. Prokhorenko
Lyubov A. Tashireva
Nadezhda N. Musina
Irina V. Dronova
The associations of incretin hormone concentration with gestational diabetes mellitus
description Background: Enteropancreatic hormonal system disorder is a possible reason for β-cell dysfunction and carbohydrate metabolism disorder among pregnant women. However, no information is available about the state of enteroinsulin hormones [glucagon, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide1 (GLP-1) and GLP-2] during pregnancy. The role of enteroinsulin hormones in the development of carbohydrate metabolism disorder during pregnancy is poorly understood. Aim: To quantify and compare incretin hormone secretion in groups of pregnant women with and without gestational diabetes mellitus (GDM). Materials and methods: The study included 80 patients, 50 of whom had GDM, and the control group consisted of 30 pregnant women without GDM. All patients underwent an oral glucose tolerance test; glycated haemoglobin (HbA1c) estimation; ferritin, transferrin, basal and postprandial glucagon estimation; GLP-1 and GLP-2 estimation. Results: Basal glucagon and GLP-1 levels were significantly higher (p <0. 05) in the group of women with GDM than in the control group. The most significant differences in GLP-1, basal and postprandial glucagon levels were observed during the first trimester of pregnancy. Conclusion: High GLP-1 levels in the group of women with GDM may reflect a state of ‘incretin resistance’, which is similar to hyperinsulinemia in the early stages of type 2 diabetes mellitus.
format article
author Tatiana V. Saprina
Ekaterina S. Timokhina
Olga K. Goncharevich
Svetlana V. Budeeva
Tatiana S. Prokhorenko
Lyubov A. Tashireva
Nadezhda N. Musina
Irina V. Dronova
author_facet Tatiana V. Saprina
Ekaterina S. Timokhina
Olga K. Goncharevich
Svetlana V. Budeeva
Tatiana S. Prokhorenko
Lyubov A. Tashireva
Nadezhda N. Musina
Irina V. Dronova
author_sort Tatiana V. Saprina
title The associations of incretin hormone concentration with gestational diabetes mellitus
title_short The associations of incretin hormone concentration with gestational diabetes mellitus
title_full The associations of incretin hormone concentration with gestational diabetes mellitus
title_fullStr The associations of incretin hormone concentration with gestational diabetes mellitus
title_full_unstemmed The associations of incretin hormone concentration with gestational diabetes mellitus
title_sort associations of incretin hormone concentration with gestational diabetes mellitus
publisher Endocrinology Research Centre
publishDate 2016
url https://doaj.org/article/152a9f78f6864022a6056a32d20297ce
work_keys_str_mv AT tatianavsaprina theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT ekaterinastimokhina theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT olgakgoncharevich theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT svetlanavbudeeva theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT tatianasprokhorenko theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT lyubovatashireva theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT nadezhdanmusina theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT irinavdronova theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT tatianavsaprina associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT ekaterinastimokhina associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT olgakgoncharevich associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT svetlanavbudeeva associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT tatianasprokhorenko associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT lyubovatashireva associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT nadezhdanmusina associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
AT irinavdronova associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus
_version_ 1718429510334939136